Skip to main content
ORIGINAL RESEARCH

Honest Care Insights

Q3/Q4 2025

GLP-1 Access Report

Coverage denials and patient access patterns. 51% face formulary exclusion, 52% required step therapy, 59% paying out-of-pocket.

1,000+ U.S. patients
Coming Soon

More Research

We're analyzing more data on appeal outcomes, insurer patterns, and coverage trends. Check back for updates.

About Our Research

Honest Care collects structured data from patients seeking help with GLP-1 insurance denials. We publish aggregated, de-identified findings to help patients, providers, and journalists understand coverage barriers.

All research is transparent about methodology and limitations. See our methodology.

Disclaimer

The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.

While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.